Ophthalmology

Adherence to Mediterranean diet lowers risk of progression to late AMD, large drusen

Stephen Padilla, 2 days ago

Closer adherence to a Mediterranean-type diet appears to reduce the risk of progression to large drusen and to late age-related macular degeneration (AMD), with the signal being greater for geographic atrophy (GA) than neovascular AMD, as shown in a retrospective analysis of two controlled clinical trials cohorts, namely Age-Related Eye Disease Study (AREDS) and AREDS2.

Proton beam therapy combined with intravitreal anti-VEGF safe, effective for eAMD

4 days ago

The combination of proton beam therapy with the intravitreal administration of anti-vascular endothelial growth factor (VEGF) reduces the need for anti-VEGF reinjection in the eyes of patients with exudative age-related macular degeneration (eAMD), a recent study has shown.

Cortical cataracts tied to systemic meds

Tristan Manalac, 5 days ago

Treatment with systemic medications, such as angiotensin converting enzyme (ACE) inhibitors, fibrates, and alpha-glucosidase inhibitors (AGIs), is associated with cortical cataract in Asians, according to a recent Singapore study.

Which toric IOL formula best predicts postoperative astigmatic outcome?

21 Nov 2020

A new study has shown that using the Kane toric formula significantly enhances the prediction of postoperative astigmatic outcome in comparison to other modern toric intraocular lens (IOL) formulas analysed.

Standardized guidelines reduce overprescribing of opioids after ophthalmic surgery

20 Nov 2020

Overprescribing of opioids after ophthalmic surgery can be reduced without increasing refill rates by standardizing opioid prescribing guidelines and discussing postsurgical pain management, suggests a recent study. Continued education is also needed to improve adherence to the prescribing guidelines.

Dry eye symptoms slow work productivity, activity level

18 Nov 2020

Individuals with dry eye disease (DED) are less productive at work and have low activity levels, and the greater the severity of DED symptoms, the lower the productivity and activity, according to data from the Dry Eye Assessment and Management (DREAM) study.

Novel drug delivery system reduces treatment burden in neovascular AMD

Dr. David Eichenbaum, Dr. Dilsher Dhoot, Prof. Peter Campochiaro, Dr. Timothy Y Y Lai, 04 Sep 2020

Intravitreal injection of antiangiogenic agents is the standard of care for neovascular age-related macular degeneration (nAMD), however, frequent injections represent a considerable treatment burden for patients. Results of the Ladder and Archway studies, presented at the 38th Annual Meeting of the American Society of Retina Specialists (ASRS 2020), showed that administration of ranibizumab through a port delivery system (PDS) considerably reduced treatment burden, while maintaining comparable efficacy and safety vs intravitreal injections. In an interview with MIMS Doctor, Dr Timothy Lai of Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, discusses how PDS may transform the management of nAMD.

No increased ophthalmic risk with roxadustat treatment in DD CKD-related anaemia

Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.